2022. Immune Checkpoint Inhibitor Therapy in Cancer: Success versus Limitations. Biomedical Research and Therapy. 9, 12 (Dec. 2022), 5455–5464. DOI:https://doi.org/10.15419/bmrat.v9i12.784.